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Our experiments aimed to clarify the mechanism by which
host cell apoptosis is inhibited by infection with the intracel-
lular protozoan parasite, Toxoplasma gondii (T. gondii). Mouse
spleen cells were cultured in 6-well plates with RPMI 1640/
10% FBS at 37 , in a 5% CO2 atmosphere. Apoptosis of
spleen cells was induced by actinomycin-D (AD) treatment for
1 h prior to infection with T. gondii. A variety of assays were
used to assess the progression of apoptosis: DNA size analysis
on agarose gel electrophoresis, flow cytometry with annexin
V/PI staining, and analysis of expression levels of Bcl-2 family
and NF- B mRNA and proteins by RT-PCR, Western blotting, κ
and EMSA. Additionally, transmission electron microscopy
(TEM) was performed to observe changes in cell morphology.
Fragmentation of DNA was inhibited in spleen cells treated
with AD and T. gondii 5 h and 18 h post infection, respec-
tively, and flow cytometry studies showed a decreased
apoptotic rates in AD and T. gondii treated spleen cells. We
observed decreased expression of Bax mRNA and protein,
while levels of Bcl-2 mRNA remained constant in spleen cells
treated with AD and T. gondii. Caspase 3 and PARP were
inactivated in cells treated with AD and T. gondii, and
increased levels of cleaved caspase 8 were also observed.
Analysis of EMSA and Western blot data suggests that
activation of transcription factor NF- B may be involved in κ
the blockade of apoptosis by T. gondii. TEM analysis showed
nuclear fragmentation and chromatin condensation occurring
in spleen cells treated with AD; however, such apoptosis-
associated morphological changes were not observed in cells
treated with both AD and T. gondii tachyzoites. Together,
these data show that T. gondii infection inhibits AD induced
apoptosis via caspase inactivation and NF- B activation in κ
mouse spleen cells.
Key Words: Toxoplasma, apoptosis, Bcl-2 family, caspase,
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INTRODUCTION
Toxoplasma gondii (T. gondii) is an obligate intra-
cellular protozoan parasite that causes congenital
infections in newborns and opportunistic infec-
tions in immunocompromised patients, such as
those with AIDS. T. gondii infects all nucleated
cells, eventually causing the host cell to rupture
following replication of the tachyzoite.
Cell survival or death, as induced by apoptosis,
is a physiological response to cell damage caused
by external and internal stimuli, and the exact fate
of a cell depends on the balance of pro-apoptotic
and anti-apoptotic proteins. Apoptosis limits the
growth of infectious agents and plays a crucial
role in the immune response. There are two path-
ways of apoptosis of cells: one triggered by death
signals, and another involving the mitochondria.
Activation of death receptors triggers the cleavage
of caspase 8, whereas release of cytochrome c
from mitochondria activates caspase 9; both
pathways eventually converge to activate the ex-
ecution caspase, caspase 3.
1 While the pathogens
Acanthamoeba sp. and E. histolytica can induce host
cell apoptosis,
2-4 the anti- or pro-apoptotic activi-
ties associated with T. gondii remain controversial.
Induction of apoptosis in Peyer's patch T cells and
the ocular tissue of mice infected with T. gondii
has been reported.
5,6 The Fas/Fas L pathway may
play a crucial role in the induction of IFN-γ
mediated apoptosis in N. caninum and T. gondii
infected cells,
7 and infection with T. gondii (RH
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strain) results in an over production of IFN- and γ
high levels of apoptosis.
8 Conversely, some intra-
cellular protozoa have the ability to inhibit host
cell apoptotic responses. T. gondii activates a
survival response in infected cells by increasing
host resistance to multiple apoptotic stimuli.
9 In
the present study, we focus on the inhibition of
apoptosis in mouse spleen cells infected with T.
gondii using morphological, molecular, and bio-
chemical approaches to characterize the role of
NF- B in the anti-apoptotic response. κ
MATERIALS AND METHODS
Toxoplasma gondii
T. gondii tachyzoites (RH) were maintained in
the peritoneal cavity of ICR mice (Dae-Han BioLink
Co., Eumseong-gun, Chungcheongbuk-do, Korea)
for three to four days. Tachyzoites were harvested
in RPMI 1640 medium (Invitrogen, Carlsbad, CA,
USA) from the peritoneal cavity and separated
from peritoneal cells by repeated low and high
speed centrifugation (40 × g for 5 min and 650 ×
g for 10 min).
Treatment of mouse spleen cells with T. gondii
infection and actinomycin-D
Spleen cells in RPMI 1640 media were harvested
from BALB/c mice and pelleted by centrifugation
(650 × g for 10 min). Cells were resuspended in
lysis buffer (0.83% NH4Cl-0.01M Tris-HCl) in
order to remove red blood cells. Mouse spleen
cells (5 × 10
6 cells/well) were cultured in 6-well
plates with RPMI 1640 media containing 2 mM
L-glutamine, 2 mg/mL NaHCO3, 10% fetal bovine
serum (FBS, Cambrex, Walkersville, MD, USA),
100 U/mL penicillin, and 100 g/mL streptomycin μ
at 37 , 5% CO2 atmosphere. Cells were infected
with 5 × 10
7 T. gondii tachyzoites and/or treated
with 5 - 10 g/mL actinomycin-D (AD, Sigma- μ
Aldrich, St. Louis, MO, USA) for 5 h and 18 h,
respectively.
DNA size analysis by agarose gel electrophoresis
Infected and non-infected mouse spleen cells
were harvested by centrifugation and resus-
pended in NET buffer containing 10% SDS, DNA-
free Rnase, and proteinase K. The cells were then
centrifuged at 12,000 × g for 5 min at 4 , and
DNA was extracted from the cell pellet with
phenol, phenol/isoamyl alcohol, and chloroform,
followed by precipitation with 100% ethanol and
10 M NH4OAc. The DNA was dissolved in TE
buffer and quantified by A260 on a spectrophoto-
meter (Perkin Elmer, Wellesley, MA, USA). DNA
samples were analyzed on a 2% agarose gel
stained with 1 g/mL ethidium bromide. μ
Flow cytometry
Cells were stained with annexin V using the
Annexin V/PI kit (R&D systems, Minneapolis,
MN, USA), and apoptotic cells identified and
quantified by flow cytometry. Briefly, spleen cells
(1 × 10
6) were washed in PBS and incubated with
10 X binding buffer, propidium iodide (PI),
annexin V-FITC, and dH2O (total 100 L) for 15 μ
min at room temperature. The apoptotic cells
were analyzed on a fluorescence-activated cell
sorter (FACS, Becton Dickinson-FACScalibur,
Cockeysville, MD, USA).
Reverse transcriptase (RT)-PCR
Bcl-2 family messenger RNA was identified by
RT-PCR using message specific primers. Mouse
spleen cells were incubated with AD and AD/T.
gondii for 30 min, 60 min or 120 min, and total
cellular RNA extracted using TRIzol (Invitrogen),
chloroform, and isopropyl alcohol. Reverse tran-
scription was performed with an oligo dT primer,
and cDNAs were amplified by PCR using the
primers listed in Table 1. PCR products were
resolved on a 2% agarose gel stained with 1 g/ μ
mL ethidium bromide.
Western blot analysis of Bcl-2 family proteins and
caspases
The abundance of Bcl-2 family proteins (Bax,
Bcl-2, Bcl-XL), caspase 3, caspase 8, PARP and
actin in mouse spleen cells was analyzed by
Western blotting. Spleen cells (5 × 10
5) were re-
suspended in lysis buffer (20 mM Tris-HCl, PHJi-Young Kim, et al.
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7.5, 60 mM beta-glycerophosphate, 10 mM EDTA,
10 mM MgCl2, 10 mM NaF, 2 mM DTT, 1 mM
Na3VO4, 1 mM APMSF, 1% Np-40, 5 g/mL μ
leupeptin). Following a 40 min incubation on ice,
the lysates were combined with 2 X sample buffer
(0.125 M Tris-HCl, pH 6.8, 4% SDS, 20% glycerol,
10% 2-mercaptoethanol, 0.2% bromphenol blue)
and boiled for 5 min, samples were resolved on
a SDS-polyacrylamide gel. After semi-dry transfer
to a PVDF membrane (Amersham Pharmacia
Biotech, Uppsala, Sweden), ponceau S staining
was used to confirm loading of equal amounts of
total protein loaded in each lane. The membranes
were blocked (5% nonfat dried milk, 0.1% Tween
20, 100 mM NaCl, 10 mM Tris-HCl, PH 7.6) for 1h
and incubated with the appropriate primary
antibody: monoclonal mouse anti-Bax antibody
(BD PharMingen, San Diego, CA, USA, 2 g/mL), μ
polyclonal rabbit anti-Bak antibody (BD Phar
Mingen, 2 g/mL), monoclonal mouse anti-Bcl-2 μ
antibody (Oncogene, San Diego, CA, USA, 2 g/ μ
mL), polyclonal rabbit anti-caspase 3 antibody
(Cell Signaling, Beverly, MA, USA, 1:100), mono-
clonal mouse anti-poly (ADP-ribose) polymerase
(PARP) antibody (BD Phar Mingen, 1:200),
polyclonal rabbit anti-caspase 8 antibody (Santa
Cruz Biotechnology, Santa Cruz, CA, USA, 1:200),
or polyclonal rabbit anti-actin antibody (Santa
Cruz Biotechnology, 1:200). Bound primary anti-
bodies were visualized with an ECL anti-mouse
IgG peroxidase-linked species-specific F(ab')2 frag-
ment (Amersham Pharmacia Biotech, 1:10,000) or
an ECL anti-rabbit IgG peroxidase-linked species-
specific F(ab')2 fragment (1:200,000) and the ECL
PLUS chemiluminescence detection system em-
ployed according to the manufacture's instruc-
tions (Amersham Pharmacia Biotech).
Western blot for NF- B and I B κ κ α
Nuclear and cytoplasmic fractions were pre-
pared from spleen cells.
10 Monoclonal mouse I B κ α
antibody (Cell signaling, 1:100), rabbit phospho-
NF- B p65 antibody (Cell signaling, 1:50), NF- B κ κ
p65 antibody (Cell signaling, 1:100) and mouse
anti-actin antibody (Chemicon international,
Temecula, CA, USA, 1:1,000) were used for detec-
tion of NF- B and I B by Western blot as de κ κ α -
scribed above.
11
Electrophoresis motility shift assay (EMSA)
Nuclear extracts from spleen cells were pre-
pared as previously described.
10 Protein concen-
trations of the nuclear extracts were determined
by Bradford assay, and EMSAs were performed
according to the manufacture's instructions
(Promega, Madison, WI, USA). Briefly, 5 g of μ
nuclear extract was incubated with a (γ
32P)-labeled
oligonucleotide probe corresponding to the con-
sensus NF- B binding site for 30 min at room κ
temperature. After incubation, bound and free
DNAs were resolved on a 5% polyacrylamide
gel
12 run at 100 V for 3 h, dried, and subjected to
autoradiography for 12 h to 48 h.
13
Transmission electron microscopy (TEM)
The apoptotic changes of mouse spleen cells
treated with AD (10 g/mL) and/or infected with μ
Table 1. Primer Sequences and RT-PCR Conditions
Gene of interest Primer PCR conditions
Bax (S)
(AS)
5'-AAGCTGAGCGAGTGTCTCCGGCG-3'
5'-GCCACAAAGATGGTCTGCC-3'
95 (10 min) - 95 (30 s) - 64 (30 s) -72 (30 s)
- 72 (7 min)
Bcl-2 (S)
(AS)
5'-CAGCTGCACCTGACGCCCTT-3'
5'-GCCTCCGTTATCCTGGATCC-3'
95 (10 min) - 95 (1 min) - 52 (1min) -72 (1 min)
- 72 (7 min)
Bcl-XL (S)
(AS)
5'-TGGAGTAAACTGGGGGTCGCATCG-3'
5'-AGCCACCGTCATTCCCGTCAGG-3'
95 (10 min) - 95 (1 min) - 50 (1 min) - 72 (1 min)
- 72 (7 min)
-actin (S) β
(AS)
5'-CCAGAGCAAGAGAGGTATCC-3'
5'-CTGTGGTGGTGAAGCTGTAG-3'
95 (10 min) - 95 (45 s) - 58 (2 min 30 s)
- 72 (10 min)Toxoplasma gondii Inhibits Apoptosis in Infected Cells by Caspase Inactivation and NF- B Activation κ
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T. gondii (3 × 10
6, cell:tachyzoite = 1:10) for 6 h in
6 well plates were visualized by TEM performed
using standard methods. Briefly, spleen cells were
fixed in 3% glutaraldehyde (PH 7.8) for 3 h at
room temperature and post-fixed in 1% osmium
tetroxide for 1.5 h at 4 . After serial dehydration
with 50%, 70% and 100% ethanol, specimens were
embedded in Epon resin. Ultrathin sections were
loaded onto copper grids; stained with uranyl ace-
tate and lead citrate, and visualized with a trans-
mission electron microscope H-7600s (Hitachi,
Tokyo, Japan).
RESULTS
DNA fragmentation in spleen cells was sup-
pressed by T. gondii
Spleen cells were incubated with AD and/or T.
gondii tachyzoites for 5 h and 18 h respectively at
37 . DNA was then extracted from spleen cells,
resolved on a 2% agarose gel, and stained with
ethidium bromide. DNA laddering was observed
in mouse spleen cells treated with AD for 5 h
(data not shown) and 18 h (Fig. 1, lanes 1 & 2).
Apoptosis was down regulated in mouse spleen
cells treated with AD and infected with T. gondii
(Fig. 1, lane 6). Spleen cells infected with T. gondii
only showed weak DNA fragmentation (Fig. 1,
lane 5). DNA laddering was observed in spleen
cells for 18h incubation, but not in freshly isolated
cells (Fig. 1, lanes 3 & 4). Similar results were
found upon repeated experiments.
Inhibition of apoptosis in spleen cells infected
with T. gondii was observed by flow cytometric
analysis
Mouse spleen cells treated with AD and/or T.
gondii infection were pooled, incubated with
annexin-FITC V and PI, and analyzed by flow
cytometry. Early apoptotic cells have increased
annexin V, but not PI staining. Late apoptotic or
necrotic cells stain with both annexin V and PI.
Mouse spleen cells cultured with AD, AD/T.
Fig. 1. Fragmentation patterns of DNA from mouse spleen
cells treated with actinomycin-D and/or T. gondii for 18 h.
Fragmentation of DNA was down regulated in cells treated
with AD/T. gondii (lane 6). Spleen cells infected with T.
gondii exhibited only weak DNA fragmentation (lane 5).
Lane 1. spleen cells treated with actinomycin-D (5 g/mL); μ
2. spleen cells treated with actinomycin-D (10 g/mL); 3. μ
normal spleen cells for 18h incubation; 4. fresh normal
spleen cells; 5. T. gondii infected spleen cells (cell:parasite
= 1:10); 6. spleen cells infected with T. gondii and treated
with actinomycin-D (5 g/mL). In repeated experi μ ments,
similar results were shown.
Fig. 2. Flow cytometric analysis of apoptosis in mouse
spleen cells treated with actinomycin-D and/or T. gondii
for 18 h. (%) indicates level of apoptosis. (A) actinomycin-
D (5 g/mL), 80.3%; (B) actinomycin-D (10 μ g/mL), 81.2%; μ
(C) normal spleen cells for 18h incubation, 39.6%; (D)
freshly isolated spleen cells, 23.8%; (E) T. gondii infected,
18.2%; (F) T. gondii and actinomycin-D treated spleen cells,
30.1%. Flow cytometry was repeated more than three
times and similar results were observed.Ji-Young Kim, et al.
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gondii and freshly isolated cells showed apoptosis
of 43.6%, 37.0%, and 15.8%, respectively after
incubation for 5 h (data not shown). The quantity
of apoptotic spleen cells were 80.3%, 30.1%, and
23.8%, respectively, after incubation for 18 h (Fig.
2, A, D, F). Similar results were found upon
repeated experiments.
Levels of Bax mRNA and protein expression in
spleen cells were reduced upon treatment with
T. gondii
RT-PCR analysis of Bcl-2 family genes was
performed on mouse spleen cells incubated with
AD, or AD/T. gondii for 30 min, 60 min or 120
min at 37 . Expression of pro-apoptotic Bax
mRNA was down regulated in AD/T. gondii
infected spleen cells (Fig. 3). Western blot an-
alysis showed that the production of Bax protein
was decreased in spleen cells treated with AD and
infected with T. gondii, while Bak protein levels
remained unchanged (Fig. 4). Expression levels of
anti-apoptotic Bcl-2 and Bcl-XL mRNAs remained
constant in spleen cells treated with AD and in-
fected with T. gondii (Fig. 3). Spleen cells infected
with T. gondii showed indistinct Bax and Bcl-2
mRNA levels. Moreover, Bcl-2 protein did not
appear in AD/T. gondii infected cells.
Caspase 3 and PARP protein activation was
suppressed in T. gondii infected spleen cells
Activation of caspase 3 and PARP proteins was
suppressed in spleen cells treated with AD and
infected with T. gondii. Down regulated, cleaved
caspase 3 at 120 min post infection and reduced
production of PARP in T. gondii infected cells
were detected by Western blotting (Fig. 4).
Although cleaved caspase 8 was observed in
spleen cells treated with AD and infected with T.
gondii, it was not expressed in spleen cells treated
with AD only (Fig. 4).
Activation of NF- B in spleen cells infected with κ
T. gondii
We examined the role of NF- B in the anti- κ
apoptotic response of T. gondii infected spleen
cells by EMSA and Western blotting. NF- B κ
activity was apparent at 120 min in spleen cells
treated with AD and infected with T. gondii, which
decreased by 180 min (Fig. 5A). T. gondii infected
spleen cells showed more activated NF-kB than
uninfected cells at 60 min on EMSA. A similar
pattern of NF- B activity in total cell and nuclear κ
extracts was observed by Western blot (Fig. 5B).
Decreased I B was associated with increased NF- κ α
B activity. κ
Fig. 3. RT-PCR analysis of Bcl-2 family genes in mouse
spleen cells. Expression of pro-apoptotic Bax mRNA was
down regulated and levels of anti-apoptotic Bcl-2 and
Bcl-XL mRNA remained constant in spleen cells treated
with AD/T. gondii. Spleen cells were co-cultured with
either actinomycin-D and/or T. gondii for 30 min, 60 min,
or 120 min followed by extraction of total cellular RNA..
(M): marker; (-): negative; (AD): actinomycin-D (5 g/ μ
mL); (AD + T.g): actinomycin-D + T. gondii infection.
Fig. 4. Western blot analysis of Bcl-2 family proteins,
caspase 3, caspase 8 and PARP in mouse spleen cells in
the presence or absence of T. gondii and actinomycin-D
after incubation for 0 min, 60 min or 120 min. Production
of Bax protein was decreased in spleen cells treated with
AD/T. gondii, while levels of Bak protein was unchanged.
Down regulation of cleaved caspase 3 at 120 min post
infection and reduced production of PARP in T. gondii
infected cells was detected by Western blotting. (AD):
actinomycin-D (5 g/mL); (AD μ + T.g): actinomycin-D + T.
gondii infection.
(min)
Bax
Bcl-2
Bcl-XL
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TEM shows inhibition of apoptosis in T. gondii
infected spleen cells
Condensation of nuclear chromatin and nuclear
fragmentation was observed in spleen cells treated
with AD (Fig. 6A & B); however, these two events
were not observed in spleen cells treated with AD
and infected with T. gondii tachyzoites (Fig. 6C &
D). In spleen cells infected with T. gondii only,
neither nuclear condensation nor fragmentation
was observed (Fig. 6E).
DISCUSSION
Apoptosis, a mechanism of programmed cell
death, is a result of both physical and pathological
events. Transduction of pro-apoptotic stimuli via
signaling pathways results in the activation of the
caspase family of cysteine proteases. Bcl-2 family
pro-apoptotic proteins promote cell death by
inducing mitochondrial damage, cytochrome c
release, and subsequent caspase activation, and
the Bcl-2 family of anti-apoptotic proteins inhibit
apoptosis by preventing the release of cytochrome
c; however, the mechanism by which parasites
utilize this method of apoptotic inhibition has not
been elucidated. Down-regulation of host cell
apoptosis may also provide an explanation for the
persistence of intracellular pathogens. T. gondii
has several strategies for inhibiting the initiation
of the apoptotic cascade. In the present study, we
found that apoptosis was not induced in mouse
spleen cells infected with T. gondii when com-
pared to uninfected controls (data not shown);
however, apoptosis was induced in spleen cells by
treatment with AD only. One biochemical analysis
of apoptosis activity is the presence of oligonu-
Fig. 5. Increased NF- B and decreased I B of mouse κ κ α
spleen cells by T. gondii infection was observed. (A) NF- B κ
activity was apparent at 120 min in spleen cells treated
with AD and infected with T. gondii on EMSA. (B) De-
creased cytosolic I B , pNF- B and increased nuclear NF- κ α κ κ
B proteins were detected in spleen cells treated with
AD/T. gondii by Western blot. (+): TNF- (20 α ng/mL);
(AD): actinomycin-D; (AD + T. gondii): actinomycin-D + T.
gondii; (CP): cytosolic proteins; (NP): nuclear proteins.
Fig. 6. Ultrastructural morphology of mouse spleen cells
treated with actinomycin-D and T. gondii after cultivation
in vitro for 6h. Condensation of nuclear chromatin and
fragmentation of the nucleus were observed in spleen cells
treated with AD (A & B); however, these events were not
observed in cells treated with AD/T. gondii tachyzoites (C
& D) or T. gondii only(E). A, B: Spleen cells treated AD (5
g/mL); C, D: Spleen cells treated with AD and μ T. gondii;
E: Spleen cells treated with T. gondii; F: Normal spleen
cells. A, B, E and F: 6000 ×, C: 7000 ×, D: 4000 ×, Bar =
2 m. The arrows and arrow heads indicate apoptotic μ
spleen cells (A & B) and T. gondii tachyzoites, respectively
(C, D & E).Ji-Young Kim, et al.
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cleosome-sized fragments of DNA, which produce
ladders when analyzed with agarose gel electro-
phoresis. Our results indicated that the induction
of DNA fragmentation in AD treated spleen cells
was inhibited by T. gondii infection (Fig. 1).
Apoptotic cells can be detected by the binding of
fluorescent labeled annexin V to the plasma
membrane. As such, early and late apoptotic cells
were measured by flow cytometric analysis after
double staining with FITC-conjugated annexin V
and PI.
14 While flow cytometric analysis could not
differentiate late apoptosis and necrosis of cells, it
demonstrated that concomitant infection with T.
gondii abrogated AD induced apoptosis. Specifi-
cally, in the AD treated population, 80.3% of cells
were apoptotic, as opposed to 30.1% of the cells
treated with both AD and T. gondii after incuba-
tion for 18 h (Fig. 2). Proteins of the Bcl-2 family
with pro-apoptosis or anti-apoptotic functions
reside in the outer mitochondrial membrane. Bax,
a pro-apoptotic protein, triggers the release of
cytochrome c from mitochondria.
1 Conversely,
Bcl-2 and Bcl-XL are capable of blocking the
release of cytochrome c, thereby preventing the
activation of caspase 9. The induction of apoptosis
by T. vaginalis is associated with a reduction of
expression of anti-apoptotic Bcl-XL protein, but
not Bcl-2, and the activation of caspase 9 suggests
that mitochondria play a role in T. vaginalis-
induced RAW 264.7 programmed cell death.
13 RT-
PCR analysis demonstrated that T. gondii infection
promotes the activation of anti-apoptotic Bcl-2
family members but not pro-apoptotic pathways.
15
Our studies showed that the expression of Bax
mRNA and protein was indistinct in AD/T.
gondii-treated mouse spleen cells, compared to
uninfected cells (Fig. 3). Likewise, expression of
Bcl-2 and Bcl-XL mRNA and Bak protein were
unchanged in mouse spleen cells treated with AD
and infected with T. gondii (Figs. 3 & 4). These
results suggested that the anti-apoptotic Bcl-2
protein was not affected in T. gondii infection and
that the other anti-apoptotic protein, Bcl-XL may
be involved. Generally T. gondii infection pro-
motes the suppression of pro-apoptotic Bax, but
not anti-apoptotic Bcl-2 proteins (Fig. 4).
Caspase 3 is a critical downstream member of
the caspase family, and is an essential effector of
apoptosis. The resistance of T. gondii infected cells
to apoptosis may be attributed to prevention of
caspase 3 activity.
1,7,16 In the present study, inacti-
vation of caspase 3 at 120 min post infection and
decreased PARP were present in cells treated AD
and infected with T. gondii as determined by
Western blotting (Fig. 4). Cleaved caspase 8, which
was present in cells treated with AD and T. gondii
infection, may have induced a weak apoptosis
response. We propose that AD did not trigger
apoptosis via the caspase 8 pathway and that
infection by the parasite induced apoptosis
slightly. Activation of the caspase cascade leads to
cleavage of a variety of target proteins including
PARP, nuclear lamins, and protein kinase C (PKC);
both PARP protein levels and cleavage of nuclear
target proteins are down regulated by T. gondii.
16
Our results showed that T. gondii mediates
inhibition of apoptosis by a blockade of Bax ex-
pression and caspase 3 activation. Inhibition of
apoptosis by T. gondii is regulated at the
transcriptional level of NF- B, as infection with κ T.
gondii induces the activation of NF- B and the κ
transcription of anti-apoptotic genes.
17-21 Phos-
phorylation of I B activates and promotes NF- B κ κ
translocation to the nucleus, where NF- B asso κ -
ciates with the transcription of proinflammatory
mediators. Further, expression of NF- B is κ
correlated with anti- apoptotic protein expression
after T. gondii infection. In this experiment, spleen
cells treated with AD and infected with T. gondii
showed increased NF- B DNA binding activity by κ
EMSA (Fig. 5). Condensation of chromatin,
disruption of nuclear architecture, vacuolation of
the cytoplasm, membrane blebbing, detachment
from substrate, and cell shrinkage are some of the
morphological changes associated with apoptosis.
We observed some of these morphologic changes
in cells treated with AD and/or T. gondii using
TEM. Condensed chromatin and fragmented
nuclei of cells were apparent 6 h after treatment
of the cells with AD; however, there were no
apoptotic changes in cells treated with AD and T.
gondii (Fig. 6C & D). In contrast to the inhibition
of apoptosis in T. gondii infected cells, parasite
infection induced apoptosis has been reported in
neighboring non-invaded cells.
5,6,22 However, we
were unable to identify such changes in uninfected
mouse spleen cells on TEM (Fig. 6D & E).
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an anti-apoptotic effect, which was associated
with inactivation of caspase 3 and PARP. Host cell
mitochondria around the parasitophorous vacuole
may be involved in anti-apoptotic activity by T.
gondii.
18 To survive in host cells, parasitic protozoa
modulate their host's apoptotic response. These
findings suggest that mouse spleen cells infected
with T. gondii resisted AD treatment, an apoptotic
stimuli, by inactivating the caspase cascade and
suppressing Bax protein expression through NF-κ
B activation. These results provide direction for
further investigation of the mechanism of inhibi-
tion of apoptosis by T. gondii in host cells.
REFERENCES
1. Payne JM, Molestina RE, Sinai AP. Inhibition of caspase
activation and requirement for NF- B function in the κ
Toxoplasma gondii-mediated blockade of host apoptosis.
J Cell Sci 2003;116:4345-58.
2. Shin HJ, Cho MS, Kim HI, Lee M, Park S, Sohn S, et
al. Apoptosis of primary-culture rat microglial cells
induced by pathogenic Acanthamoeba spp. Clin Diagn
Lab Immunol 2000;7:510-4.
3. Sim S, Kim KA, Yong TS, Park SJ, Im KI, Shin MH.
Ultrastructural observation of human neutrophils
during apoptotic cell death triggered by Entamoeba
histolytica. Korean J Parasitol 2004;42:205-8.
4. Sim S, Yong TS, Park SJ, Im KI, Kong Y, Ryu JS, et al.
NADPH oxidase-derived reactive oxygen species-
mediated activation of ERK1/2 is required for
apoptosis of human neutrophils induced by Entamoeba
histolytica. J Immunol 2005;174:4279-88.
5. Liesenfeld O, Kosek JC, Suzuki Y. Gamma interferon
induces Fas-dependent apoptosis of Peyer's patch T
cells in mice following peroral infection with Toxoplasma
gondii. Infect Immun 1997;65:4682-9.
6. Hu MS, Schwartzman JD, Yeaman GR, Collins J, Seguin
R, Khan IA, et al. Fas-FasL interaction involved in
pathogenesis of ocular toxoplasmosis in mice. Infect
Immun 1999;67:928-35.
7. Nishikawa Y, Makala L, Otsuka H, Mikami T, Nagasawa
H. Mechanisms of apoptosis in murine fibroblasts by
two intracellular protozoan parasites, Toxoplasma gondii
and Neospora caninum. Parasite Immunol 2002;24:347-
54.
8. Gavrilescu LC, Denkers EY. IFN- overproduction and γ
high level apoptosis are associated with high but not
low virulence Toxoplasma gondii infection. J Immunol
2001;167:902-9.
9. Nash PB, Purner MB, Leon RP, Clarke P, Duke RC,
Curiel TJ. Toxoplasma gondii-infected cells are resistant
to multiple inducers of apoptosis. J Immunol 1998;160:
1824-30.
10. Kim JS, Kim JM, Jung HC, Song IS. Caspase-3 activity
and expression of Bcl-2 family in human neutrophils by
Helicobacter pylori water-soluble proteins. Helicobacter
2001;6:207-15.
11. Elewaut D, DiDonato JA, Kim JM, Truong F, Eckmann
L, Kagnoff MF. NF- B is a central regulator of the intes κ -
tinal epithelial cell innate immune response induced by
infection with enteroinvasive bacteria. J Immunol 1999;
163:1457-66.
12. Kim JM, Oh YK, Kim YJ, Cho SJ, Ahn MH, Cho YJ.
Nuclear factor-kappa B plays a major role in the regula-
tion of chemokine expression of HeLa cells in response
to Toxoplasma gondii infection. Parasitol Res 2001;87:
758-63.
13. Chang JH, Ryang YS, Morio T, Lee SK, Chang EJ.
Trichomonas vaginalis inhibits proinflammatory cyto-
kine production in macrophages by suppressing NF- B κ
activation. Mol Cells 2004;18:177-85.
14. Kim JM, Eckmann L, Savidge TC, Lowe DC, Witthoft
T, Kagnoff MF. Apoptosis of human intestinal epithelial
cells after bacterial invasion. J Clin Invest 1998;102:
1815-23.
15. Goebel S, Luder CG, Gross U. Invasion by Toxoplasma
gondii protects human-derived HL-60 cells from actino-
mycin D-induced apoptosis. Med Microbiol Immunol
1999;187:221-6.
16. Goebel S, Gross U, Luder CG. Inhibition of host cell
apoptosis by Toxoplasma gondii is accompanied by
reduced activation of the caspase cascade and altera-
tions of poly (ADP-ribose) polymerase expression. J
Cell Sci 2001;114:3495-505.
17. Heussler VT, Kuenzi P, Rottenberg S. Inhibition of
apoptosis by intracellular protozoan parasites. Int J
Parasitol 2001;31:1166-76.
18. Molestina RE, Payne TM, Coppens I, Sinai AP. Activa-
tion of NF-kappaB by Toxoplasma gondii correlates with
increased expression of antiapoptotic genes and locali-
zation of phosphorylated IkappaB to the parasito-
phorous vacuole membrane. J Cell Sci 2003;116:4359-
71.
19. Denkers EY, Butcher BA, Del Rio L, Kim L. Manipula-
tion of mitogen-activated protein kinase/nuclear factor-
kappa B-signaling cascades during intracellular Toxoplasma
gondii infection. Immunol Rev 2004;201:191-205.
20. Carmen JC, Hardi L, Sinai AP. Toxoplasma gondii
inhibits ultraviolet light-induced apoptosis through
multiple interactions with the mitochondrion-depen-
dent programmed cell death pathway. Cell Microbiol
2006;8:301-15.
21. Sinai AP, Payne TM, Carmen JC, Hardi L, Watson SJ,
Molestina RE. Mechanisms underlying the manipula-
tion of host apoptotic pathways by Toxoplasma gondii.
Int J Parasitol 2004;34:381-91.
22. James ER, Green DR. Manipulation of apoptosis in the
host-parasite interaction. Trends Parasitol 2004;20:280-
7.